![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 24, 25058-25065, June 11, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶
From the
Institut für Molekularbiologie und Biophysik, Eidgenössische Technische Hochschule Hönggerberg and
Elektronenmikroskopie-Zentrum der ETH Zürich,
Institut für Angewandte Physik, Eidgenössische Technische Hochschule Hönggerberg, CH-8093 Zürich, Switzerland
An abnormal isoform, PrPSc, of the normal cellular prion protein (PrPC) is the major component of the causative agent of prion diseases. Both isoforms were found to possess the same covalent structures, including a C-terminal glycosylphosphatidylinositol anchor, but different secondary and tertiary structures. In this study, a variant of full-length PrP with an unpaired cysteine at the C terminus was recombinantly produced in Escherichia coli, covalently coupled to a thiol-reactive phospholipid, and incorporated into liposomes to serve as a model for studying possible changes in structure and stability of recombinant PrP upon membrane attachment. Covalent coupling of PrP to liposomes did not result in significant structural changes observable by far-UV circular dichroism. Moreover, limited proteolysis experiments failed to detect changes in the stability of liposome-bound PrP relative to soluble PrP. These data suggest that the requirement of raft localization for the PrPC to PrPSc conversion, observed previously in cell culture models, is not because of a direct influence of raft lipids on the structure and stability of membranebound PrPC but caused by other factors, e.g. increased local PrP concentrations or high effective concentrations of membrane-associated conversion factors. The availability of recombinant PrP covalently attached to liposomes provides the basis for systematic in vitro conversion assays with recombinant PrP on the surface of membranes. In addition, our results indicate that the three-dimensional structure of mammalian PrPC in membranes is identical to that of recombinant PrP in solution.
Received for publication, January 28, 2004 , and in revised form, March 16, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Institut für Molekularbiologie und Biophysik, Eidgenössische Technische Hochschule Hönggerberg, CH-8093 Zürich, Switzerland. Tel.: 41-1-6336819; Fax: 41-1-6331036; E-mail: rudi{at}mol.biol.ethz.ch.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani Physiology of the Prion Protein Physiol Rev, April 1, 2008; 88(2): 673 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barret, L. Forestier, J.-P. Deslys, R. Julien, and P. F. Gallet Glycosylation-related Gene Expression in Prion Diseases: PrPSc ACCUMULATION IN SCRAPIE INFECTED GT1 CELLS DEPENDS ON {beta}-1,4-LINKED GalNAc-4-SO4 HYPOSULFATION J. Biol. Chem., March 18, 2005; 280(11): 10516 - 10523. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Lysek, C. Schorn, L. G. Nivon, V. Esteve-Moya, B. Christen, L. Calzolai, C. von Schroetter, F. Fiorito, T. Herrmann, P. Guntert, et al. Prion protein NMR structures of cats, dogs, pigs, and sheep PNAS, January 18, 2005; 102(3): 640 - 645. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |